Insider Transactions in Q1 2023 at Celularity Inc (CELU)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2023
|
Robert J Hariri Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,084,854
+17.03%
|
$0
$0.83 P/Share
|
|
Mar 15
2023
|
Kyle Fletcher Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,170
-0.84%
|
$0
$0.63 P/Share
|
|
Feb 17
2023
|
John R Haines Officer |
BUY
Grant, award, or other acquisition
|
Direct |
400,000
+46.21%
|
-
|
|
Feb 17
2023
|
Kyle Fletcher Officer |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+46.47%
|
-
|
|
Feb 17
2023
|
Stephen Brigido Pres, Functional Regeneration |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+46.21%
|
-
|
|
Feb 17
2023
|
Bradley Glover Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+45.87%
|
-
|
|
Feb 17
2023
|
David C Beers Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
250,000
+46.21%
|
-
|
|
Feb 17
2023
|
Adrian Kilcoyne Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
300,000
+50.0%
|
-
|
|
Feb 10
2023
|
Peter Diamandis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,071,000
+49.17%
|
$0
$0.28 P/Share
|